BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 30295183)

  • 1. Aptamer-Based Targeted Drug Delivery Systems: Current Potential and Challenges.
    He F; Wen N; Xiao D; Yan J; Xiong H; Cai S; Liu Z; Liu Y
    Curr Med Chem; 2020; 27(13):2189-2219. PubMed ID: 30295183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
    Li X; Zhao Q; Qiu L
    J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-specific aptamers and their conjugation with nanomaterials for targeted drug delivery.
    Liao J; Liu B; Liu J; Zhang J; Chen K; Liu H
    Expert Opin Drug Deliv; 2015 Mar; 12(3):493-506. PubMed ID: 25430795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigations on the interface of nucleic acid aptamers and binding targets.
    Cai S; Yan J; Xiong H; Liu Y; Peng D; Liu Z
    Analyst; 2018 Nov; 143(22):5317-5338. PubMed ID: 30357118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of Cancer Cell-Specific Aptamers in Targeted Delivery of Anticancer Therapeutic Agents.
    Kim M; Kim DM; Kim KS; Jung W; Kim DE
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29617327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An exploration of aptamer internalization mechanisms and their applications in drug delivery.
    Wan LY; Yuan WF; Ai WB; Ai YW; Wang JJ; Chu LY; Zhang YQ; Wu JF
    Expert Opin Drug Deliv; 2019 Mar; 16(3):207-218. PubMed ID: 30691313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery Systems.
    Jiang F; Liu B; Lu J; Li F; Li D; Liang C; Dang L; Liu J; He B; Badshah SA; Lu C; He X; Guo B; Zhang XB; Tan W; Lu A; Zhang G
    Int J Mol Sci; 2015 Oct; 16(10):23784-822. PubMed ID: 26473828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aptamer applications for targeted cancer therapy.
    Barbas AS; Mi J; Clary BM; White RR
    Future Oncol; 2010 Jul; 6(7):1117-26. PubMed ID: 20624124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in aptamer-mediated targeted delivery system for cancer treatment.
    He S; Du Y; Tao H; Duan H
    Int J Biol Macromol; 2023 May; 238():124173. PubMed ID: 36965552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptamers as Versatile Ligands for Biomedical and Pharmaceutical Applications.
    Guan B; Zhang X
    Int J Nanomedicine; 2020; 15():1059-1071. PubMed ID: 32110008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted siRNA delivery using aptamer-siRNA chimeras and aptamer-conjugated nanoparticles.
    Sivakumar P; Kim S; Kang HC; Shim MS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 May; 11(3):e1543. PubMed ID: 30070426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development and testing of aptamers for cancer.
    Barbas AS; White RR
    Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted cancer drug delivery with aptamer-functionalized polymeric nanoparticles.
    Zununi Vahed S; Fathi N; Samiei M; Maleki Dizaj S; Sharifi S
    J Drug Target; 2019 Mar; 27(3):292-299. PubMed ID: 29929413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the development of aptamer drug conjugates for targeted drug delivery.
    Chen K; Liu B; Yu B; Zhong W; Lu Y; Zhang J; Liao J; Liu J; Pu Y; Qiu L; Zhang L; Liu H; Tan W
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 May; 9(3):. PubMed ID: 27800663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamers Chemistry: Chemical Modifications and Conjugation Strategies.
    Odeh F; Nsairat H; Alshaer W; Ismail MA; Esawi E; Qaqish B; Bawab AA; Ismail SI
    Molecules; 2019 Dec; 25(1):. PubMed ID: 31861277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AS1411 derivatives as carriers of G-quadruplex ligands for cervical cancer cells.
    Figueiredo J; Lopes-Nunes J; Carvalho J; Antunes F; Ribeiro M; Campello MPC; Paulo A; Paiva A; Salgado GF; Queiroz JA; Mergny JL; Cruz C
    Int J Pharm; 2019 Sep; 568():118511. PubMed ID: 31301466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy.
    Fu Z; Xiang J
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in the study of aptamer-based drug for targeting therapy].
    Dou XQ; Fu J; Song HF
    Yao Xue Xue Bao; 2016 Jul; 51(7):1068-76. PubMed ID: 29897179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine.
    Zhuo Z; Yu Y; Wang M; Li J; Zhang Z; Liu J; Wu X; Lu A; Zhang G; Zhang B
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic potential of cell-internalizing aptamers.
    Zhou J; Rossi JJ
    Curr Top Med Chem; 2009; 9(12):1144-57. PubMed ID: 19860714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.